WHO ICTRP trial
Real-World Study of Ceftazidime and Avibactam Sodium for Injection and Sodium…
ChiCTR2500103407 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500103407 |
|---|---|
| Public title | Real-World Study of Ceftazidime and Avibactam Sodium for Injection and Sodium Chloride Injection in ICU Patients with Severe Infections: Effectiveness, Safety, and Convenience |
| Scientific title | Real-World Study of Ceftazidime and Avibactam Sodium for Injection and Sodium Chloride Injection in ICU Patients with Severe Infections: Effectiveness, Safety, and Convenience |
| Primary sponsor | Affiliated Hospital of Jinggangshan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Countries | China |
| Conditions | cIAI; HAP/VAP; Gram-negative bacterial infections that are sensitive to CAZ-AVI and have limited therapeutic options. |
| Interventions | Observation group:None |
| Registration date | May 28, 2025 |
| Target size | Observation group:60 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: